This is suspected to be true for MCC as well, corroborated by a study by Ramirez-Fort et al., in which immunohistochemistry performed on 81 primary and metastatic MCC lesions showed prevalent PSMA expression associated with the tumor neovasculature in 67% (54/81) of patients [40]. This evidence concerns the gene FOLH1 and neoplasm.